Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Investing Cash Flow
$3.96M
Quarterly · Period ending: · USD
LCTX Investing Cash Flow
Latest reported$3.96Mperiod ending
Latest reported$3.96Mperiod ending
LCTX Quarterly Cash from Investing ($0.00 → $3.96M)
Quarterly investing cash flow
High-resolution chart · PNG
LCTX investing cash flow history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| 3,960,000 | |
| -2,326,000 | |
| -15,334,000 | |
| -12,000 | |
| -14,000 | |
| 1,903,000 | |
| 2,635,000 | |
| 3,888,000 | |
| -8,793,000 | |
| -38,000 | |
| 9,742,000 | |
| 2,122,000 | |
| 19,159,000 | |
| 15,426,000 | |
| -5,102,000 | |
| -40,914,000 | |
| -97,000 | |
| -46,000 | |
| -146,000 | |
| -68,000 | |
| -115,000 | |
| 10,074,000 | |
| 902,000 | |
| 178,000 | |
| 6,702,000 | |
| 5,256,000 | |
| 720,000 | |
| 13,485,000 | |
| -194,000 | |
| 2,946,000 | |
| 9,784,000 | |
| -138,000 | |
| -41,000 | |
| 2,211,000 | |
| -583,000 | |
| 4,842,000 | |
| -5,330,000 | |
| -9,154,000 | |
| -409,000 | |
| -464,000 | |
| -8,351,000 | |
| -1,665,000 | |
| -2,588,000 | |
| -2,027,000 | |
| -2,452,611 | |
| -373,389 | |
| -208,441 | |
| -92,468 | |
| -179,277 | |
| -527,618 | |
| -1,658,522 | |
| -1,217,518 | |
| -238,996 | |
| -550,551 | |
| -195,910 | |
| -51,648 | |
| 260,000 | |
| -117,129 | |
| -429,997 | |
| -242,563 | |
| -242,170 | |
| -287,983 | |
| 3,904,869 | |
| -271,667 | |
| -190,057 | |
| -245,726 | |
| -5,629 | |
| -25,632 | |
| -7,675 | |
| -7,290 | |
| -108,482 | |
| -550,000 | |
| -250,000 | |
| -1,389 | |
| -4,694 | |
| 0 | |
| 0 | |
| -1,779 | |
| -4,721 | |
| -5,943 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -3,831 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |